BCBS Florida Medical Policy Updates – July 2022

Click here to view the Blue Cross Blue Shield BCBS Florida Medical Policy Updates »

July 2022 BCBS Florida Medical Policy Updates:

• Abatacept (Orencia) Injection and Infusion
• Abortion
• Adalimumab (Humira ) Injection
• Allergy Testing and Immunotherapy
• Anakinra (Kineret ) Injection
• Apremilast (Otezla ) Tablet
• Baricitinib (Olumiant) Tablet
• Belantamab Mafodotin-blmf (Blenrep ) IV Infusion
• Bortezomib Injection
• Botulinum Toxins
• Brodalumab (Siliq) Injection
• Carfilzomib (Kyprolis) Injection
• Certolizumab Pegol (Cimzia) Injection
• Daratumumab (Darzalex ) Infusion and Daratumumab-Hyaluronidase-fihj (Darzalex Faspro ) Injection
• Durable Medical Equipment (DME)
• Eculizumab (Soliris®) Injection
• Efgartigimod alfa-fcab (Vyvgart) injection
• Elotuzumab (Empliciti ) Injection
• Endovascular Procedures for Intracranial Arterial Disease (Atherosclerosis and Aneurysms) and Extracranial Vertebral Artery Disease
• Erythropoiesis Stimulating Agents
• Etanercept (Enbrel) Injection
• Fam-trastuzumab deruxtecan-nxki injection (Enhertu)
• Genetic Testing
• Golimumab (Simponi, Simponi Aria) Injection and Infusion
• Guselkumab (Tremfya) Injection
• Hospital Beds and Accessories
• Hyperthermic Intraperitoneal Chemotherapy (HIPEC)
• Implantable Cardioverter Defibrillators/ Cardiac Contractility Modulation (CCM) Therapy
• Implantation of Intrastromal Corneal Ring Segments
• Inebilizumab (Uplizna) Injection
• Infliximab Products
• Ipilimumab (Yervoy™) Injection
• Isatuximab-irfc (Sarclisa®) Infusion
• Ixazomib (Ninlaro ) Capsule
• Ixekizumab (Taltz) Injection
• Lanreotide (Somatuline® Depot) Injection
• Lonafarnib (Zokinvy)
• Mitapivat (Pyrukynd)
• Neuropsychological Testing
• Nivolumab (Opdivo)
• Occipital Nerve Stimulation
• Octreotide Acetate (Sandostatin LAR  Depot, Bynfezia Pen™, Mycapssa Capsule)
• Peanut (Arachis hypogaea) Allergen Powder- dnfd (Palforzia)
• Pegcetacoplan (Empaveli)
• Pegvaliase-pqpz (Palynziq)
• Physical Therapy (PT) and Occupational Therapy (OT)
• Preventive Services
• Ravulizumab (Ultomiris™) IV
• Risankizumab-rzaa (Skyrizi) Injection
• Sarilumab (Kevzara) Injection
• Satralizumab (Enspryng)
• Secukinumab (Cosentyx ) Injection
• Tafasitamab-cxix (Monjuvi) IV Infusion
• Tocilizumab (Actemra ) Injection and Infusion
• Tofacitinib (Xeljanz , Xeljanz  XR) Oral Solution
• Upadacitinib (Rinvoq) Tablets
• Ustekinumab (Stelara) Injection and Infusion
• Voclosporin (Lupkynis)
• Voxelotor (Oxbryta™)

Click here to view the Blue Cross Blue Shield BCBS Florida Medical Policy Updates »

Policy Alerts monitors Commercial and Medicare medical policies for changes. While medical Insurance carriers typically update medical policies annually, there are many reasons why they might review or update a policy. When reviews occur out of cycle they often go unnoticed. Policy Alerts keeps you updated when Payers make coverage changes to medical policies affecting your business.

Policy Alerts continuously monitors Commercial and Medicare Payer coverage information to keep you up-to-date on medical Insurance decisions in real-time. When changes occur, instant email alerts are delivered to your inbox. Clients have access to detailed coverage reports and medical policies through the interactive Policy Alerts Dashboard portal. Save time each month and keep focused on important Payer medical policy reviews and coverage decisions affecting your business!

Policy Alerts takes a client-focused hands-on approach and is constantly working to provide our customers with helpful insights and actionable analytics. We understand what our clients need and are dedicated to providing timely, accurate, and always up-to-date reports.

Health economic and reimbursement information provided by Policy Alerts is gathered from third-party sources and is subject to change without notice as a result of complex and frequently changing laws, regulations, rules and policies. All product and company names are trademarks™ or registered® trademarks of their respective holders. Use of them does not imply any affiliation with or endorsement by them. This information is presented for illustrative purposes only and does not constitute reimbursement or legal advice.